Description
Fabiflu Tablet (Favipiravir) – Antiviral Treatment for Mild to Moderate COVID-19
Fabiflu Tablet is an antiviral medication specifically formulated for the treatment of mild to moderate COVID-19 in adults. Containing Favipiravir as its active ingredient, it works by inhibiting the replication of the SARS-CoV-2 virus, thereby reducing viral load in the body. This helps manage symptoms and may speed up recovery time. Fabiflu is most effective when initiated early in the course of infection. It’s crucial to take this medication exactly as prescribed by your healthcare provider, completing the full course even if symptoms improve earlier. Patients should be aware that Fabiflu is not a substitute for COVID-19 vaccination or preventive measures.
Uses of Fabiflu Tablet:
- Treatment of mild to moderate COVID-19 in adults
- Reduction of SARS-CoV-2 viral load
- Management of COVID-19 symptoms
Benefits of Fabiflu Tablet:
- Targets viral replication directly
- May help reduce symptom duration
- Potentially decreases disease progression risk
- Oral tablet form for convenient administration
Side Effects of Fabiflu Tablet:
- Increased uric acid levels
- Diarrhea
- Decreased white blood cell count (neutropenia)
- Elevated liver enzymes
- Increased triglyceride levels
- Potential gout flare-ups
How to Use Fabiflu Tablet?
- Take exactly as prescribed by your doctor
- Typical dosage: 1,800mg twice on Day 1, then 800mg twice daily for up to 14 days
- Swallow tablets whole with water
- Can be taken with or without food
- Maintain consistent dosing times
- Complete the full prescribed course
How Fabiflu Tablet Works?
Fabiflu contains Favipiravir, an antiviral compound that acts as a RNA polymerase inhibitor. It gets incorporated into the viral RNA chain during replication, causing premature termination of viral RNA synthesis. This mechanism effectively stops the SARS-CoV-2 virus from multiplying, reducing viral load and helping the immune system combat the infection more effectively.
Safety Advice:
- Pregnancy: Strictly contraindicated – may cause fetal harm
- Breastfeeding: Not recommended – potential infant toxicity
- Alcohol: Avoid – potential interaction unknown
- Kidney/Liver Disease: Requires dose adjustment and monitoring
- Gout/Hyperuricemia: Use with extreme caution
- Contraception: Required during and for 7 days post-treatment
What If You Miss a Dose?
Take the missed dose as soon as remembered unless it’s within 4 hours of the next dose. Never take double doses. If multiple doses are missed, consult your healthcare provider for guidance.
Important Drug Interactions:
- Hormonal Contraceptives: Reduced effectiveness – use backup methods
- Uricosuric Agents: May require adjustment
- Immunosuppressants: Potential increased risk of neutropenia
- Hepatotoxic Drugs: Increased liver enzyme risk
FAQs:
Q1. When should the treatment be started?
Initiate as soon as possible after COVID-19 diagnosis when symptoms are still mild to moderate for optimal effectiveness.
Q2. Can Fabiflu prevent COVID-19 infection?
No, it’s a treatment for active infection, not a preventive measure. Continue all recommended precautions.
Q3. Who should avoid Fabiflu?
Pregnant/breastfeeding women, children, those with severe kidney/liver impairment, gout patients, and anyone allergic to Favipiravir.
Q4. How should Fabiflu be stored?
Store below 30°C in original packaging, away from moisture and children’s reach.
Q5. Can I stop taking Fabiflu if symptoms improve?
No, complete the full prescribed course to ensure viral clearance and prevent resistance.
Q6. Does Fabiflu interact with vaccines?
No known interactions, but consult your doctor about optimal timing for vaccination post-treatment.
Q7. What monitoring is required during treatment?
Regular tests for liver function, uric acid levels, and complete blood counts are recommended.
Q8. Can Fabiflu cause serious side effects?
While generally well-tolerated, it may cause significant changes in blood parameters requiring medical attention.
There are no reviews yet.